Clinical Trial Update: Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing fluconazole with FK463 to prevent fungal infections in bone marrow transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Candidiasis
• Fungemia
• Mycoses

Drugs mentioned

• FK463 (FK463)
• Fluconazole (Fluconazole)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Aspergillosis, Candidiasis | Phase 3 | Status: COMPLETED